Drug
Smecta
Smecta: highest development phase Post-Market, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Smecta NCT02704091 | Post-Market | Acute Diarrhoea |
Latest
No recent events.
Follow Smecta on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.